Ibuprom Sport Spray (Ibuprofen)

Ibuprofen in Ibuprom Sport Spray acts locally on the inflammatory cascade to alleviate pain and swelling in musculoskeletal conditions.

• Muscle pain: provides topical analgesia and reduces inflammation in sore muscles.
• Sports injuries: eases discomfort and swelling from minor strains or overuse.
• Sprains: helps diminish pain and localized edema in ligament sprains.
• Bruises: lessens tenderness and discoloration associated with contusions.
• Localized inflammation: targets prostaglandin‑mediated swelling at the application site.

• Ibuprofen inhibits cyclooxygenase (COX‑1 and COX‑2) enzymes in peripheral tissues, decreasing the synthesis of prostaglandins that mediate pain, inflammation and fever. When applied topically, the drug penetrates the skin to reach underlying muscle and joint structures, delivering a localized anti‑inflammatory effect while minimizing systemic exposure. The reduction in prostaglandin levels leads to decreased sensitization of nociceptors and less vascular permeability, which together contribute to pain relief and reduced swelling at the treated site.

Topical ibuprofen may cause local or systemic adverse reactions, although most users experience only mild effects.

Common Side Effects

• Skin irritation: redness, itching or mild rash at the application site.
• Burning sensation: transient warmth or tingling when first applied.
• Dryness: mild drying of the skin where the spray is used.
• Pruritus: itching without visible rash.

Serious or Rare Side Effects

• Allergic reaction: swelling of the face, lips or throat, or hives indicating possible hypersensitivity.
• Severe skin reaction: blistering, peeling or dermatitis requiring medical attention.
• Systemic toxicity: signs such as nausea, dizziness or gastrointestinal upset if excessive absorption occurs.
• Liver enzyme elevation: abnormal liver function tests suggesting hepatotoxicity.

When using Ibuprom Sport Spray, observe the following precautions to ensure safe and effective application.

• Avoid broken skin: do not apply to open wounds or damaged epidermis.
• Limit area: restrict use to a total surface area not exceeding 10% of body surface.
• Duration: do not exceed the recommended treatment period, typically three days without medical advice.
• Concomitant NSAIDs: avoid using other NSAID products simultaneously to reduce risk of systemic exposure.
• Children: keep out of reach of children; not intended for use in persons under 12 years unless directed by a clinician.
• Store at below 25°C: keep in original container, protect from moisture and direct sunlight.

Ibuprofen may interact with other medicines; consider the following when co‑administering.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased bleeding risk.
• Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity.
• Corticosteroids: heightened risk of ulceration and bleeding.
• ACE inhibitors or ARBs: potential reduction in renal function.

Moderate Interactions (Monitor Closely)

• Diuretics: possible decrease in antihypertensive effect.
• Lithium: increased lithium levels leading to toxicity.
• Methotrexate: reduced clearance may raise methotrexate toxicity.
• Antidepressants (SSRIs): modestly increased bleeding tendency.